• Skip to primary navigation
  • Skip to main content
Engineered Tissue Solutions

Engineered Tissue Solutions

  • Chronic Wound Care
    • Mirragen
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Surgical Wound Care
    • MirraSurg
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Science & Technology
  • Provider & Patient Support
    • For Providers
    • For Patients
    • Reimbursement
  • About
    • Contact Us
    • News & Events
    • Careers
    • Testimonials
  • Request Information

Faces of Mirragen® – Shan Boldt (Chicago, IL)

Meet Shan Boldt, who had been battling a toe wound for months and faced the harsh reality of a possible amputation. With the introduction of Mirragen, a borate-based bioactive glass wound matrix, Shan’s toe reached closure after just six weeks and seven applications. As a result, Shan is able to move around more freely and do the things he loves in life.

Learn how ETS is transforming wound care.

Access Literature
  • Request Information
  • Contact Us
  • Careers
  • LinkedIn
  • Facebook
  • Instagram
  • Disclaimer
  • Privacy
  • Terms & Conditions
  • Patents

MIRRAGEN® is a registered trademark of ETS Tech Holdings, LLC. | © ETS Wound Care